SARS-CoV-2：一首新歌唤起旧旋律。
SARS-CoV-2: A New Song Recalls an Old Melody.
机构信息
WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC 3000, Australia.
出版信息
Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.
Abstract
The viruses causing the SARS outbreak of 2002-2003 and current COVID-19 pandemic are related betacoronaviruses. What insights were learned from SARS that can inform SARS-CoV-2 vaccine development? Focusing on important lessons from SARS vaccine development and two SARS vaccines evaluated in humans may guide SARS-CoV-2 vaccine design, testing, and implementation.
摘要
导致 2002-2003 年 SARS 爆发和当前 COVID-19 大流行的病毒是相关的β冠状病毒。从 SARS 中获得了哪些可以为 SARS-CoV-2 疫苗开发提供信息的见解？关注 SARS 疫苗开发和在人体中评估的两种 SARS 疫苗的重要经验教训可能会指导 SARS-CoV-2 疫苗的设计、测试和实施。
相似文献
1
SARS-CoV-2: A New Song Recalls an Old Melody.SARS-CoV-2：一首新歌唤起旧旋律。
Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.
2
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.基于刺突蛋白的 SARS 亚单位疫苗候选物的保护性免疫：冠状病毒疫苗开发的经验教训。
J Immunol Res. 2020 Jul 18;2020:7201752. doi: 10.1155/2020/7201752. eCollection 2020.
3
Developing a low-cost and accessible COVID-19 vaccine for global health.为全球健康研发一种低成本且易于获取的新冠疫苗。
PLoS Negl Trop Dis. 2020 Jul 29;14(7):e0008548. doi: 10.1371/journal.pntd.0008548. eCollection 2020 Jul.
4
Coronavirus vaccines get a biotech boost.冠状病毒疫苗获得生物技术助力。
Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.
5
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.新冠病毒和非典病毒感染之间的交叉反应性抗体反应。
Cell Rep. 2020 Jun 2;31(9):107725. doi: 10.1016/j.celrep.2020.107725. Epub 2020 May 18.
6
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.2020 年大流行：当前 SARS-CoV-2 疫苗的开发。
Front Immunol. 2020 Aug 19;11:1880. doi: 10.3389/fimmu.2020.01880. eCollection 2020.
7
A systematic review of SARS-CoV-2 vaccine candidates.SARS-CoV-2 疫苗候选物的系统评价。
Signal Transduct Target Ther. 2020 Oct 13;5(1):237. doi: 10.1038/s41392-020-00352-y.
8
Coronavirus vaccine-associated lung immunopathology-what is the significance?冠状病毒疫苗相关的肺部免疫病理学——其意义何在？
Microbes Infect. 2020 Oct;22(9):403-404. doi: 10.1016/j.micinf.2020.06.007. Epub 2020 Jun 26.
9
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.一种针对严重急性呼吸综合征冠状病毒 2 刺突蛋白 RBD 的疫苗可诱导保护性免疫。
Nature. 2020 Oct;586(7830):572-577. doi: 10.1038/s41586-020-2599-8. Epub 2020 Jul 29.
10
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?针对冠状病毒感染的疫苗候选者。COVID-19 处于什么位置？
Viruses. 2020 Aug 7;12(8):861. doi: 10.3390/v12080861.
引用本文的文献
1
Immune response induced by novel coronavirus infection.新型冠状病毒感染诱导的免疫应答。
Front Cell Infect Microbiol. 2022 Oct 25;12:988604. doi: 10.3389/fcimb.2022.988604. eCollection 2022.
2
Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population.接种疫苗的孟加拉国人群中针对 SARS-CoV-2 的中和抗体的持久性差异。
Sci Rep. 2022 Aug 29;12(1):14681. doi: 10.1038/s41598-022-18302-9.
3
Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice.轻度 SARS-CoV-2 感染 K18-hACE2 小鼠诱导的长期保护性免疫
Vaccines (Basel). 2022 Apr 14;10(4):613. doi: 10.3390/vaccines10040613.
4
The success of SARS-CoV-2 vaccines and challenges ahead.新型冠状病毒疫苗的成功与未来挑战。
Cell Host Microbe. 2021 Jul 14;29(7):1111-1123. doi: 10.1016/j.chom.2021.06.016.
5
The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.多种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒抗原在疫苗诱导的综合免疫反应中的作用。
Vaccine. 2021 Apr 28;39(18):2500-2503. doi: 10.1016/j.vaccine.2021.03.067. Epub 2021 Mar 22.
6
SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response.美国应对新冠疫情下一阶段对严重急性呼吸综合征冠状病毒2血清学检测的需求
Open Forum Infect Dis. 2020 Nov 17;8(1):ofaa555. doi: 10.1093/ofid/ofaa555. eCollection 2021 Jan.
7
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
8
COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis.与糖尿病和其他非传染性疾病相关的新冠病毒病引发了一场全球健康危机。
Diabetes Res Clin Pract. 2021 Jan;171:108587. doi: 10.1016/j.diabres.2020.108587. Epub 2020 Dec 9.
9
Management strategies in a SEIR-type model of COVID 19 community spread.COVID-19 社区传播的 SEIR 型模型中的管理策略。
Sci Rep. 2020 Dec 4;10(1):21256. doi: 10.1038/s41598-020-77628-4.
10
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应，及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
本文引用的文献
1
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.新冠病毒、中东呼吸综合征病毒和严重急性呼吸综合征病毒在非人灵长类动物模型中的比较发病机制。
Science. 2020 May 29;368(6494):1012-1015. doi: 10.1126/science.abb7314. Epub 2020 Apr 17.
2
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.雪貂中 SARS-CoV-2 的感染和快速传播。
Cell Host Microbe. 2020 May 13;27(5):704-709.e2. doi: 10.1016/j.chom.2020.03.023. Epub 2020 Apr 6.
3
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
4
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.模拟新型冠状病毒肺炎（COVID-19）在金黄地鼠模型中的临床和病理表现：对疾病发病机制和传染性的影响。
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446. doi: 10.1093/cid/ciaa325.
5
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
6
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.β-丙内酯灭活全病毒 SARS-CoV 疫苗在小鼠和仓鼠中的免疫原性和保护效力。
Viral Immunol. 2010 Oct;23(5):509-19. doi: 10.1089/vim.2010.0028.
7
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.一种非典DNA疫苗在一项I期临床试验中，在健康成年人中诱导出中和抗体和细胞免疫反应。
Vaccine. 2008 Nov 25;26(50):6338-43. doi: 10.1016/j.vaccine.2008.09.026. Epub 2008 Sep 26.
8
9
Animal models and vaccines for SARS-CoV infection.用于严重急性呼吸综合征冠状病毒（SARS-CoV）感染的动物模型和疫苗。
Virus Res. 2008 Apr;133(1):20-32. doi: 10.1016/j.virusres.2007.03.025. Epub 2007 May 11.
10
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.一种适应小鼠的严重急性呼吸综合征冠状病毒可导致BALB/c小鼠发病和死亡。
PLoS Pathog. 2007 Jan;3(1):e5. doi: 10.1371/journal.ppat.0030005.
Zotero 插件